This is a non-core endpoint: only basic statistics are computed.
See its core counterpart CD2_INSITU_RECTOSIGMOID_EXALLC for full statistics.
Carcinoma in situ of rectosigmoid junction
CD2_INSITU_RECTOSIGMOID
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
10 |
4. Check minimum number of eventsNone |
10 |
5. Include endpointsNone |
10 |
6. Filter based on genotype QC (FinnGen only) |
10 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D01
- Name in latin
- Carcinoma in situ junctionis rectosigmoideae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of rectosigmoid junction
based on the number of shared cases.
Similar with more cases:
- Carcinoma in situ of rectosigmoid junction
- Carcinoma in situ of other and unspecified digestive organs
- Carcinoma in situ of other and unspecified digestive organs
- In situ neoplasms
- In situ neoplasms
Similar with less cases:
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 10 | 6 | - |
| Unadjusted period prevalence (%) | 0.00 | 0.00 | - |
| Median age at first event (years) | 63.98 | 59.64 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
5
21
3.71
1.27
6.0
3.5
—
—
—
0
0
5
61
0.64
0.29
3.8
4.4
1.2
1.2
mmol/l
—
5
56
0
11
0.00
0.23
0.0
4.8
—
29.8
—
0
6
0
10
0.00
0.23
0.0
8.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_RECTOSIGMOID – Carcinoma in situ of rectosigmoid junction
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).